- Home
- HUIZ vs PASG Comparison
HUIZ vs PASG Comparison
Compare HUIZ & PASG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUIZ
- PASG
- Stock Information
- Founded
- HUIZ 2006
- PASG 2017
- Country
- HUIZ China
- PASG United States
- Employees
- HUIZ N/A
- PASG N/A
- Industry
- HUIZ Specialty Insurers
- PASG Biotechnology: Pharmaceutical Preparations
- Sector
- HUIZ Finance
- PASG Health Care
- Exchange
- HUIZ Nasdaq
- PASG Nasdaq
- Market Cap
- HUIZ 41.7M
- PASG 42.2M
- IPO Year
- HUIZ 2020
- PASG 2020
- Fundamental
- Price
- HUIZ $0.67
- PASG $0.54
- Analyst Decision
- HUIZ
- PASG Strong Buy
- Analyst Count
- HUIZ 0
- PASG 1
- Target Price
- HUIZ N/A
- PASG $13.00
- AVG Volume (30 Days)
- HUIZ 16.1K
- PASG 234.7K
- Earning Date
- HUIZ 12-03-2024
- PASG 11-13-2024
- Dividend Yield
- HUIZ N/A
- PASG N/A
- EPS Growth
- HUIZ N/A
- PASG N/A
- EPS
- HUIZ 0.06
- PASG N/A
- Revenue
- HUIZ $154,359,355.00
- PASG N/A
- Revenue This Year
- HUIZ N/A
- PASG N/A
- Revenue Next Year
- HUIZ $10.46
- PASG N/A
- P/E Ratio
- HUIZ $11.36
- PASG N/A
- Revenue Growth
- HUIZ N/A
- PASG N/A
- 52 Week Low
- HUIZ $0.43
- PASG $0.45
- 52 Week High
- HUIZ $1.08
- PASG $1.79
- Technical
- Relative Strength Index (RSI)
- HUIZ 36.94
- PASG 43.06
- Support Level
- HUIZ $0.68
- PASG $0.45
- Resistance Level
- HUIZ $0.77
- PASG $0.68
- Average True Range (ATR)
- HUIZ 0.05
- PASG 0.06
- MACD
- HUIZ -0.01
- PASG -0.01
- Stochastic Oscillator
- HUIZ 0.06
- PASG 37.12
About HUIZ Huize Holding Limited
Huize Holding Ltd is an independent online insurance product and service platform in China. The company distributes on its platform insurance products underwritten by the insurance companies who cooperate with the company, who the company refers to as its insurer partners, and helps them reach a large number of insurance clients. The company's platform offers digitalized insurance purchase experience and services through various internet and mobile internet channels. The company generates revenues from the insurance brokerage fees paid by its insurer partners.
About PASG Passage Bio Inc.
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease.